CN113456519A - Novel separated skin care product - Google Patents
Novel separated skin care product Download PDFInfo
- Publication number
- CN113456519A CN113456519A CN202110852049.XA CN202110852049A CN113456519A CN 113456519 A CN113456519 A CN 113456519A CN 202110852049 A CN202110852049 A CN 202110852049A CN 113456519 A CN113456519 A CN 113456519A
- Authority
- CN
- China
- Prior art keywords
- agent
- skin care
- ceramide
- care product
- glycerol
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003795 chemical substances by application Substances 0.000 claims abstract description 34
- 239000007788 liquid Substances 0.000 claims abstract description 19
- 239000000843 powder Substances 0.000 claims abstract description 16
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 40
- 239000000047 product Substances 0.000 claims description 22
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 15
- -1 malto-oligosaccharide glucoside Chemical class 0.000 claims description 11
- 229940015975 1,2-hexanediol Drugs 0.000 claims description 10
- 229930182478 glucoside Natural products 0.000 claims description 10
- RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 claims description 10
- FHKSXSQHXQEMOK-UHFFFAOYSA-N hexane-1,2-diol Chemical compound CCCCC(O)CO FHKSXSQHXQEMOK-UHFFFAOYSA-N 0.000 claims description 10
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 claims description 10
- QCDWFXQBSFUVSP-UHFFFAOYSA-N 2-phenoxyethanol Chemical compound OCCOC1=CC=CC=C1 QCDWFXQBSFUVSP-UHFFFAOYSA-N 0.000 claims description 7
- 229960005323 phenoxyethanol Drugs 0.000 claims description 7
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 claims description 6
- HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 claims description 5
- GVWGRUCKLWVZRY-ATDBAKNUSA-N (2S)-2-amino-5-(diaminomethylideneamino)pentanoic acid (E)-3-(4-hydroxy-3-methoxyphenyl)prop-2-enoic acid Chemical compound OC(=O)[C@@H](N)CCCN=C(N)N.COC1=CC(\C=C\C(O)=O)=CC=C1O GVWGRUCKLWVZRY-ATDBAKNUSA-N 0.000 claims description 5
- FYGDTMLNYKFZSV-URKRLVJHSA-N (2s,3r,4s,5s,6r)-2-[(2r,4r,5r,6s)-4,5-dihydroxy-2-(hydroxymethyl)-6-[(2r,4r,5r,6s)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1[C@@H](CO)O[C@@H](OC2[C@H](O[C@H](O)[C@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O FYGDTMLNYKFZSV-URKRLVJHSA-N 0.000 claims description 5
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical class CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 claims description 5
- JKMHFZQWWAIEOD-UHFFFAOYSA-N 2-[4-(2-hydroxyethyl)piperazin-1-yl]ethanesulfonic acid Chemical compound OCC[NH+]1CCN(CCS([O-])(=O)=O)CC1 JKMHFZQWWAIEOD-UHFFFAOYSA-N 0.000 claims description 5
- ZGSCRDSBTNQPMS-UJURSFKZSA-N 3-O-Ethylascorbic acid Chemical compound CCOC1=C(O)C(=O)O[C@@H]1[C@@H](O)CO ZGSCRDSBTNQPMS-UJURSFKZSA-N 0.000 claims description 5
- 229940120145 3-o-ethylascorbic acid Drugs 0.000 claims description 5
- CSHZYWUPJWVTMQ-UHFFFAOYSA-N 4-n-Butylresorcinol Chemical compound CCCCC1=CC=C(O)C=C1O CSHZYWUPJWVTMQ-UHFFFAOYSA-N 0.000 claims description 5
- 229920002498 Beta-glucan Polymers 0.000 claims description 5
- YDNKGFDKKRUKPY-JHOUSYSJSA-N C16 ceramide Natural products CCCCCCCCCCCCCCCC(=O)N[C@@H](CO)[C@H](O)C=CCCCCCCCCCCCCC YDNKGFDKKRUKPY-JHOUSYSJSA-N 0.000 claims description 5
- QRYRORQUOLYVBU-VBKZILBWSA-N Carnosic acid Natural products CC([C@@H]1CC2)(C)CCC[C@]1(C(O)=O)C1=C2C=C(C(C)C)C(O)=C1O QRYRORQUOLYVBU-VBKZILBWSA-N 0.000 claims description 5
- 108010087806 Carnosine Proteins 0.000 claims description 5
- 241000209020 Cornus Species 0.000 claims description 5
- 102000016359 Fibronectins Human genes 0.000 claims description 5
- 108010067306 Fibronectins Proteins 0.000 claims description 5
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 5
- 108010024636 Glutathione Proteins 0.000 claims description 5
- 229920002527 Glycogen Polymers 0.000 claims description 5
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims description 5
- BBAFBDLICMHBNU-MFZOPHKMSA-N N-(2-hydroxyoctadecanoyl)-4-hydroxysphinganine Chemical compound CCCCCCCCCCCCCCCCC(O)C(=O)N[C@@H](CO)[C@H](O)[C@H](O)CCCCCCCCCCCCCC BBAFBDLICMHBNU-MFZOPHKMSA-N 0.000 claims description 5
- CRJGESKKUOMBCT-VQTJNVASSA-N N-acetylsphinganine Chemical compound CCCCCCCCCCCCCCC[C@@H](O)[C@H](CO)NC(C)=O CRJGESKKUOMBCT-VQTJNVASSA-N 0.000 claims description 5
- CQOVPNPJLQNMDC-UHFFFAOYSA-N N-beta-alanyl-L-histidine Natural products NCCC(=O)NC(C(O)=O)CC1=CN=CN1 CQOVPNPJLQNMDC-UHFFFAOYSA-N 0.000 claims description 5
- KZTJQXAANJHSCE-OIDHKYIRSA-N N-octodecanoylsphinganine Chemical compound CCCCCCCCCCCCCCCCCC(=O)N[C@@H](CO)[C@H](O)CCCCCCCCCCCCCCC KZTJQXAANJHSCE-OIDHKYIRSA-N 0.000 claims description 5
- ATGQXSBKTQANOH-UWVGARPKSA-N N-oleoylphytosphingosine Chemical compound CCCCCCCCCCCCCC[C@@H](O)[C@@H](O)[C@H](CO)NC(=O)CCCCCCC\C=C/CCCCCCCC ATGQXSBKTQANOH-UWVGARPKSA-N 0.000 claims description 5
- 229920002385 Sodium hyaluronate Polymers 0.000 claims description 5
- HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 claims description 5
- GCDXVKZXCQGDHC-BLCQCPAESA-N [30-oxo-30-[[(2s,3s,4r)-1,3,4-trihydroxyoctadecan-2-yl]amino]triacontyl] (9z,12z)-octadeca-9,12-dienoate Chemical compound CCCCCCCCCCCCCC[C@@H](O)[C@@H](O)[C@H](CO)NC(=O)CCCCCCCCCCCCCCCCCCCCCCCCCCCCCOC(=O)CCCCCCC\C=C/C\C=C/CCCCC GCDXVKZXCQGDHC-BLCQCPAESA-N 0.000 claims description 5
- HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 claims description 5
- 150000001720 carbohydrates Chemical class 0.000 claims description 5
- CQOVPNPJLQNMDC-ZETCQYMHSA-N carnosine Chemical compound [NH3+]CCC(=O)N[C@H](C([O-])=O)CC1=CNC=N1 CQOVPNPJLQNMDC-ZETCQYMHSA-N 0.000 claims description 5
- 229940044199 carnosine Drugs 0.000 claims description 5
- 229940106189 ceramide Drugs 0.000 claims description 5
- ZVEQCJWYRWKARO-UHFFFAOYSA-N ceramide Natural products CCCCCCCCCCCCCCC(O)C(=O)NC(CO)C(O)C=CCCC=C(C)CCCCCCCCC ZVEQCJWYRWKARO-UHFFFAOYSA-N 0.000 claims description 5
- 229940086668 ceramide eop Drugs 0.000 claims description 5
- 239000008103 glucose Substances 0.000 claims description 5
- 229960003180 glutathione Drugs 0.000 claims description 5
- 229940096919 glycogen Drugs 0.000 claims description 5
- 229940089468 hydroxyethylpiperazine ethane sulfonic acid Drugs 0.000 claims description 5
- 235000014655 lactic acid Nutrition 0.000 claims description 5
- 239000004310 lactic acid Substances 0.000 claims description 5
- PUGFCQQOYJMKOO-UHFFFAOYSA-N n-(3-hexadecoxy-2-hydroxypropyl)-n-(2-hydroxyethyl)hexadecanamide Chemical compound CCCCCCCCCCCCCCCCOCC(O)CN(CCO)C(=O)CCCCCCCCCCCCCCC PUGFCQQOYJMKOO-UHFFFAOYSA-N 0.000 claims description 5
- VVGIYYKRAMHVLU-UHFFFAOYSA-N newbouldiamide Natural products CCCCCCCCCCCCCCCCCCCC(O)C(O)C(O)C(CO)NC(=O)CCCCCCCCCCCCCCCCC VVGIYYKRAMHVLU-UHFFFAOYSA-N 0.000 claims description 5
- QMHBZWNZCSNBGU-UHFFFAOYSA-N nonane-1,2,3-triol Chemical compound CCCCCCC(O)C(O)CO QMHBZWNZCSNBGU-UHFFFAOYSA-N 0.000 claims description 5
- WCVRQHFDJLLWFE-UHFFFAOYSA-N pentane-1,2-diol Chemical compound CCCC(O)CO WCVRQHFDJLLWFE-UHFFFAOYSA-N 0.000 claims description 5
- 239000011734 sodium Substances 0.000 claims description 5
- 229910052708 sodium Inorganic materials 0.000 claims description 5
- 229940010747 sodium hyaluronate Drugs 0.000 claims description 5
- YWIVKILSMZOHHF-QJZPQSOGSA-N sodium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4r,5s,6r)-3-acetamido-2-[(2s,3s,4r,5r,6r)-6-[(2r,3r,4r,5s,6r)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2- Chemical compound [Na+].CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 YWIVKILSMZOHHF-QJZPQSOGSA-N 0.000 claims description 5
- 229920001285 xanthan gum Polymers 0.000 claims description 5
- 239000000230 xanthan gum Substances 0.000 claims description 5
- 229940082509 xanthan gum Drugs 0.000 claims description 5
- 235000010493 xanthan gum Nutrition 0.000 claims description 5
- 229940013368 zanthoxylum bungeanum fruit extract Drugs 0.000 claims description 5
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 claims description 4
- 108010009736 Protein Hydrolysates Proteins 0.000 claims description 4
- 229960005150 glycerol Drugs 0.000 claims description 4
- NCZPCONIKBICGS-UHFFFAOYSA-N 3-(2-ethylhexoxy)propane-1,2-diol Chemical compound CCCCC(CC)COCC(O)CO NCZPCONIKBICGS-UHFFFAOYSA-N 0.000 claims description 3
- 239000003109 Disodium ethylene diamine tetraacetate Substances 0.000 claims description 3
- ZGTMUACCHSMWAC-UHFFFAOYSA-L EDTA disodium salt (anhydrous) Chemical compound [Na+].[Na+].OC(=O)CN(CC([O-])=O)CCN(CC(O)=O)CC([O-])=O ZGTMUACCHSMWAC-UHFFFAOYSA-L 0.000 claims description 3
- 241000555712 Forsythia Species 0.000 claims description 3
- 241001598113 Laminaria digitata Species 0.000 claims description 3
- DFPAKSUCGFBDDF-ZQBYOMGUSA-N [14c]-nicotinamide Chemical compound N[14C](=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-ZQBYOMGUSA-N 0.000 claims description 3
- 230000001476 alcoholic effect Effects 0.000 claims description 3
- 235000012000 cholesterol Nutrition 0.000 claims description 3
- 235000019301 disodium ethylene diamine tetraacetate Nutrition 0.000 claims description 3
- 229940100524 ethylhexylglycerin Drugs 0.000 claims description 3
- JFQWHJPQSSMFMH-UHFFFAOYSA-N methyl 4,5,6-trimethylpyrimidine-2-carboxylate Chemical compound COC(=O)C1=NC(=C(C(=N1)C)C)C JFQWHJPQSSMFMH-UHFFFAOYSA-N 0.000 claims description 3
- ANZUDYZHSVGBRF-UHFFFAOYSA-N 3-ethylnonane-1,2,3-triol Chemical compound CCCCCCC(O)(CC)C(O)CO ANZUDYZHSVGBRF-UHFFFAOYSA-N 0.000 claims description 2
- SCVVSSZVLZQUDZ-UHFFFAOYSA-N 3-methyl-2,6-dihydro-1H-pyrimidine-2-carboxylic acid Chemical compound CN1C(NCC=C1)C(=O)O SCVVSSZVLZQUDZ-UHFFFAOYSA-N 0.000 claims description 2
- 241000512259 Ascophyllum nodosum Species 0.000 claims description 2
- KNFLNGRLKALWRF-LDXSYGEZSA-N CSCC[C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CCCCN)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](C(C)C)C(N)=O)CC1=CC=CC=C1 Chemical compound CSCC[C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CCCCN)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](C(C)C)C(N)=O)CC1=CC=CC=C1 KNFLNGRLKALWRF-LDXSYGEZSA-N 0.000 claims description 2
- DFPAKSUCGFBDDF-UHFFFAOYSA-N Nicotinamide Chemical compound NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 claims description 2
- 239000011149 active material Substances 0.000 claims description 2
- 230000008018 melting Effects 0.000 claims description 2
- 238000002844 melting Methods 0.000 claims description 2
- 229960003966 nicotinamide Drugs 0.000 claims description 2
- 235000005152 nicotinamide Nutrition 0.000 claims description 2
- 239000011570 nicotinamide Substances 0.000 claims description 2
- CDQSJQSWAWPGKG-UHFFFAOYSA-N butane-1,1-diol Chemical compound CCCC(O)O CDQSJQSWAWPGKG-UHFFFAOYSA-N 0.000 claims 1
- 239000000413 hydrolysate Substances 0.000 claims 1
- 239000013543 active substance Substances 0.000 abstract description 5
- 239000000969 carrier Substances 0.000 abstract description 3
- 239000000839 emulsion Substances 0.000 abstract description 3
- 230000007613 environmental effect Effects 0.000 abstract description 2
- 238000004519 manufacturing process Methods 0.000 abstract description 2
- 239000000654 additive Substances 0.000 abstract 1
- 230000003260 anti-sepsis Effects 0.000 abstract 1
- 239000000463 material Substances 0.000 description 5
- LXAHHHIGZXPRKQ-UHFFFAOYSA-N 5-fluoro-2-methylpyridine Chemical compound CC1=CC=C(F)C=N1 LXAHHHIGZXPRKQ-UHFFFAOYSA-N 0.000 description 2
- 241000576429 Forsythia suspensa Species 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 208000035143 Bacterial infection Diseases 0.000 description 1
- 239000012752 auxiliary agent Substances 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 208000022362 bacterial infectious disease Diseases 0.000 description 1
- 238000009395 breeding Methods 0.000 description 1
- 230000001488 breeding effect Effects 0.000 description 1
- 239000008407 cosmetic solvent Substances 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 238000001647 drug administration Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 230000001804 emulsifying effect Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012856 packing Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
- A61K8/345—Alcohols containing more than one hydroxy group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
- A61K8/347—Phenols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/36—Carboxylic acids; Salts or anhydrides thereof
- A61K8/365—Hydroxycarboxylic acids; Ketocarboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/42—Amides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
- A61K8/442—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof substituted by amido group(s)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/494—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/494—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
- A61K8/4946—Imidazoles or their condensed derivatives, e.g. benzimidazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/494—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
- A61K8/4953—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom containing pyrimidine ring derivatives, e.g. minoxidil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/55—Phosphorus compounds
- A61K8/553—Phospholipids, e.g. lecithin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/60—Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/60—Sugars; Derivatives thereof
- A61K8/602—Glycosides, e.g. rutin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/60—Sugars; Derivatives thereof
- A61K8/606—Nucleosides; Nucleotides; Nucleic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/63—Steroids; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
- A61K8/673—Vitamin B group
- A61K8/675—Vitamin B3 or vitamin B3 active, e.g. nicotinamide, nicotinic acid, nicotinyl aldehyde
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
- A61K8/676—Ascorbic acid, i.e. vitamin C
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/68—Sphingolipids, e.g. ceramides, cerebrosides, gangliosides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
- A61K8/735—Mucopolysaccharides, e.g. hyaluronic acid; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9706—Algae
- A61K8/9711—Phaeophycota or Phaeophyta [brown algae], e.g. Fucus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/20—Chemical, physico-chemical or functional or structural properties of the composition as a whole
- A61K2800/30—Characterized by the absence of a particular group of ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
- A61K2800/88—Two- or multipart kits
- A61K2800/882—Mixing prior to application
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Emergency Medicine (AREA)
- Molecular Biology (AREA)
- Botany (AREA)
- Biophysics (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Dermatology (AREA)
- Chemical & Material Sciences (AREA)
- Biochemistry (AREA)
- Cosmetics (AREA)
Abstract
The invention discloses a novel separated skin care product, which belongs to the technical field of skin care products and comprises an agent A and an agent B; the agent A and the agent B are contained separately; the agent A is active powder; the agent B is a liquid carrier. The invention provides a novel separated skin care product, which is divided into an agent A and an agent B, and is characterized in that main active substances and carriers are separately prepared and packaged, the active substances are independently packaged in the form of active powder with highest purity and high content, and the carriers are independently packaged in the form of liquid or emulsion, so that the skin care product can be instantly fused for use when in use, the use safety is improved, addition of additives such as antisepsis and the like can be avoided, and the skin care product has the characteristics of environmental protection, safety and low processing and manufacturing cost.
Description
Technical Field
The invention belongs to the technical field of skin care products, and particularly relates to a novel separated skin care product.
Background
The traditional skin care product is in a form of emulsifying and fusing active substances and carriers in different states, and is divided into a liquid state, an emulsion state, an essence state, a cream state and other main forms according to the difference of the states and the flowability. The ubiquitous life cycle of traditional mode is longer, needs control uncap back bacterial infection through adding anticorrosive system and breed, and bacterial breeding rate is higher, and unit specification packing is great usually simultaneously, therefore needs to finish of using in certain cycle. These problems are not consumer and user friendly.
Disclosure of Invention
The invention aims to solve the problems in the background art and provides a novel separated skin care product.
The invention is realized by the following technical scheme:
a novel separated skin care product comprises an agent A and an agent B; the agent A and the agent B are contained separately; the agent A is active powder; the agent B is a liquid carrier.
Furthermore, the active powder material is a water-soluble or alcohol-soluble active material raw material, and the melting point of the active powder material is not lower than 45 ℃.
Further, the liquid carrier is an aqueous or alcoholic liquid.
Further, the active powder material comprises the following components:
glutathione, trehalose, RNA sodium, 4-butyl resorcinol, water, glycerol, 1, 2-hexanediol, nonapeptide-1, hexyl glycerol, tetrahydro-methyl pyrimidine carboxylic acid, glycogen, malto-oligosaccharide glucoside, water and glucose.
Furthermore, the active powder material comprises the following components in percentage by weight:
glutathione 70%, trehalose 28.6%, RNA sodium 1%, 4-butyl resorcinol 0.1%, water 0.0708%, glycerol 0.025%, 1, 2-hexanediol 0.004%, nonapeptide-10.0001%, hexylglycerol 0.0001%, tetramethylpyrimidinecarboxylic acid 0.1%, glycogen 0.085%, maltooligosaccharide glucoside 0.0098%, water 0.005%, glucose 0.0002%.
Further, the liquid carrier consists of the following components:
water, lactic acid, butylene glycol, 1, 2-pentanediol, glycerol, 3-o-ethyl ascorbic acid, niacinamide, dogwood extract, 1-methylhydantoin-2-amide, arginine ferulate, zanthoxylum bungeanum fruit extract, forsythia suspense extract, carnosine, hydroxyethylpiperazine ethanesulfonic acid, glycerol glucoside, 1, 2-hexanediol, beta-glucan, kelp palmitake, hydrogenated lecithin, cetyl-PG hydroxyethylpalmitamide, ceramide EOP, ceramide NS, ceramide NP, ceramide AS, ceramide AP, cholesterol, saccharide hydrolysates, phenoxyethanol, fibronectin, ethylhexylglycerol, disodium EDTA, xanthan gum, sodium hyaluronate.
Further, the liquid carrier consists of the following components in percentage by weight:
83.1979% of water, 0.5% of lactic acid, 4.5% of butylene glycol, 0.1% of 1, 2-pentanediol, 3.3545% of glycerol, 3-o-ethyl ascorbic acid, 3% of nicotinamide, 2% of dogwood extract, 0.6% of 1-methylhydantoin-2-amide, 0.05% of arginine ferulate, 0.36% of zanthoxylum bungeanum fruit extract, 0.24% of forsythia suspensa extract, 0.5% of carnosine, 0.5% of hydroxyethylpiperazine ethanesulfonic acid, 0.15% of glycerol glucoside, 0.3025% of 1, 2-hexanediol, 0.2% of beta-glucan, 0.002% of Laminaria digitata, 0.0009% of hydrogenated lecithin, 0.00009% of cetyl-PG hydroxyethylpalmitamide, 0.00009% of ceramide EOP, 0.00009% of ceramide NS, 0.00009% of ceramide NP, 0.00009% of ceramide AS, 0.00009% of ceramide AP, 0.00009% of saccharide hydrolysate, 0.004% of phenoxyethanol, 0.6% of phenoxyethanol, Fibronectin 0.0002%, ethylhexylglycerin 0.0001%, EDTA disodium 0.045%, xanthan gum 0.03%, and sodium hyaluronate 0.01%.
Compared with the prior art, the invention has the following advantages:
the invention provides a novel separated skin care product, which is divided into an agent A and an agent B, and is characterized in that main active substances and a carrier are separately prepared and packaged, the active substances are independently packaged in the form of active powder with highest purity and high content, and the carrier is independently packaged in the form of liquid or emulsion, so that the skin care product can be instantly fused for use when in use, the use safety is improved, addition of auxiliary agents such as anticorrosion and the like can be avoided, and the skin care product has the characteristics of environmental protection, safety and low processing and manufacturing cost, and has great market competitiveness.
Detailed Description
In order to make the objects, technical solutions and advantages of the present invention more apparent, the present invention will be described in further detail with reference to the following examples. It should be understood that the specific embodiments described herein are merely illustrative of the invention and are not intended to limit the invention.
Example 1
A novel separated skin care product comprises an agent A and an agent B; the agent A and the agent B are contained separately; the agent A is active powder; the agent B is a liquid carrier.
The active powder is the raw material of the skin conditioner type within the regulation range of the national drug administration; the liquid carrier used is a conventional cosmetic solvent, and an aqueous or alcoholic liquid is preferable here.
Example 2
A novel separated skin care product comprises an agent A and an agent B; the agent A and the agent B are contained separately; the agent A is active powder; the agent B is a liquid carrier.
The active powder material comprises the following components in percentage by weight:
glutathione 70%, trehalose 28.6%, RNA sodium 1%, 4-butyl resorcinol 0.1%, water 0.0708%, glycerol 0.025%, 1, 2-hexanediol 0.004%, nonapeptide-10.0001%, hexylglycerol 0.0001%, tetramethylpyrimidinecarboxylic acid 0.1%, glycogen 0.085%, maltooligosaccharide glucoside 0.0098%, water 0.005%, glucose 0.0002%.
The liquid carrier consists of the following components in percentage by weight:
83.1979% of water, 0.5% of lactic acid, 4.5% of butylene glycol, 0.1% of 1, 2-pentanediol, 3.3545% of glycerol, 3-o-ethyl ascorbic acid, 3% of nicotinamide, 2% of dogwood extract, 0.6% of 1-methylhydantoin-2-amide, 0.05% of arginine ferulate, 0.36% of zanthoxylum bungeanum fruit extract, 0.24% of forsythia suspensa extract, 0.5% of carnosine, 0.5% of hydroxyethylpiperazine ethanesulfonic acid, 0.15% of glycerol glucoside, 0.3025% of 1, 2-hexanediol, 0.2% of beta-glucan, 0.002% of Laminaria digitata, 0.0009% of hydrogenated lecithin, 0.00009% of cetyl-PG hydroxyethylpalmitamide, 0.00009% of ceramide EOP, 0.00009% of ceramide NS, 0.00009% of ceramide NP, 0.00009% of ceramide AS, 0.00009% of ceramide AP, 0.00009% of saccharide hydrolysate, 0.004% of phenoxyethanol, 0.6% of phenoxyethanol, Fibronectin 0.0002%, ethylhexylglycerin 0.0001%, EDTA disodium 0.045%, xanthan gum 0.03%, and sodium hyaluronate 0.01%.
The skin care products of the present invention differ from conventional skin care products as follows:
in conclusion, compared with the existing skin care products, the skin care product of the invention has obvious improvement on the aspects of safety, use effect and the like, and has great market competitiveness.
The above description is only for the purpose of illustrating the preferred embodiments of the present invention, and the present invention is not limited to the illustrated embodiments, and all the modifications and equivalents of the embodiments may be made without departing from the spirit of the present invention.
Claims (7)
1. A novel separated skin care product is characterized by comprising an agent A and an agent B; the agent A and the agent B are contained separately; the agent A is active powder; the agent B is a liquid carrier.
2. The novel skin care product of claim 1, wherein the active powder is a water-soluble or alcohol-soluble active material and has a melting point of not less than 45 ℃.
3. The novel separate skin care product according to claim 1, wherein the liquid carrier is an aqueous or alcoholic liquid.
4. The novel skin care product of claim 1, wherein the active powder comprises the following components:
glutathione, trehalose, RNA sodium, 4-butyl resorcinol, water, glycerol, 1, 2-hexanediol, nonapeptide-1, hexyl glycerol, tetrahydro-methyl pyrimidine carboxylic acid, glycogen, malto-oligosaccharide glucoside, water and glucose.
5. The novel separate skin care product of claim 4, wherein the active powder comprises the following components in percentage by weight:
glutathione 70%, trehalose 28.6%, RNA sodium 1%, 4-butyl resorcinol 0.1%, water 0.0708%, glycerol 0.025%, 1, 2-hexanediol 0.004%, nonapeptide-10.0001%, hexylglycerol 0.0001%, tetramethylpyrimidinecarboxylic acid 0.1%, glycogen 0.085%, maltooligosaccharide glucoside 0.0098%, water 0.005%, glucose 0.0002%.
6. A novel separate skin care product according to claim 1, wherein said liquid carrier is composed of:
water, lactic acid, butylene glycol, 1, 2-pentanediol, glycerol, 3-o-ethyl ascorbic acid, niacinamide, dogwood extract, 1-methylhydantoin-2-amide, arginine ferulate, zanthoxylum bungeanum fruit extract, forsythia suspense extract, carnosine, hydroxyethylpiperazine ethanesulfonic acid, glycerol glucoside, 1, 2-hexanediol, beta-glucan, kelp palmitake, hydrogenated lecithin, cetyl-PG hydroxyethylpalmitamide, ceramide EOP, ceramide NS, ceramide NP, ceramide AS, ceramide AP, cholesterol, saccharide hydrolysates, phenoxyethanol, fibronectin, ethylhexylglycerol, disodium EDTA, xanthan gum, sodium hyaluronate.
7. The novel separate skin care product of claim 6, wherein the liquid carrier comprises the following components in percentage by weight:
83.1979% of water, 0.5% of lactic acid, 4.5% of butanediol, 0.1% of 1, 2-pentanediol, 3.3545% of glycerol, 3-o-ethyl ascorbic acid, 3% of nicotinamide, 2% of dogwood extract, 0.6% of 1-methylhydantoin-2-amide, 0.05% of arginine ferulate, 0.36% of zanthoxylum bungeanum fruit extract, 0.24% of forsythia extract, 0.5% of carnosine, 0.5% of hydroxyethylpiperazine ethanesulfonic acid, 0.15% of glycerol glucoside, 0.3025% of 1, 2-hexanediol, and the like,
Beta-glucan 0.2%, Laminaria digitata 0.002%, hydrogenated lecithin 0.0009%, cetyl-PG hydroxyethyl palmitamide 0.00009%, ceramide EOP 0.00009%, ceramide NS 0.00009%, ceramide NP 0.00009%, ceramide AS 0.00009%, ceramide AP 0.00009%, cholesterol 0.00009%, saccharide hydrolysate 0.004%, phenoxyethanol 0.0006%, fibronectin 0.0002%, ethylhexylglycerin 0.0001%, disodium EDTA 0.045%, xanthan gum 0.03%, and sodium hyaluronate 0.01%.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202110852049.XA CN113456519A (en) | 2021-07-27 | 2021-07-27 | Novel separated skin care product |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202110852049.XA CN113456519A (en) | 2021-07-27 | 2021-07-27 | Novel separated skin care product |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN113456519A true CN113456519A (en) | 2021-10-01 |
Family
ID=77882870
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202110852049.XA Pending CN113456519A (en) | 2021-07-27 | 2021-07-27 | Novel separated skin care product |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN113456519A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN115444772A (en) * | 2022-10-26 | 2022-12-09 | 广州艾卓生物科技股份有限公司 | Moisturizing and whitening composition and application thereof in radio frequency beauty treatment and medical beauty skin care |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN109662898A (en) * | 2018-12-06 | 2019-04-23 | 上海益好纳米科技有限公司 | A kind of novel solid skin care item and preparation method thereof |
| CN110638682A (en) * | 2019-11-01 | 2020-01-03 | 广州启妆生物科技有限公司 | Jiudai peptide composite freeze-dried powder and preparation method thereof |
-
2021
- 2021-07-27 CN CN202110852049.XA patent/CN113456519A/en active Pending
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN109662898A (en) * | 2018-12-06 | 2019-04-23 | 上海益好纳米科技有限公司 | A kind of novel solid skin care item and preparation method thereof |
| CN110638682A (en) * | 2019-11-01 | 2020-01-03 | 广州启妆生物科技有限公司 | Jiudai peptide composite freeze-dried powder and preparation method thereof |
Non-Patent Citations (2)
| Title |
|---|
| 佚名: ""依薇蓝谷胱甘肽亮颜冻干粉+谷胱甘肽亮颜冻干粉溶媒"", 《百度》 * |
| 广州微肽生物科技有限公司: ""依薇蓝谷胱甘肽亮颜冻干粉+谷胱甘肽亮颜冻干粉溶媒"", 《国产普通化妆品备案信息》 * |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN115444772A (en) * | 2022-10-26 | 2022-12-09 | 广州艾卓生物科技股份有限公司 | Moisturizing and whitening composition and application thereof in radio frequency beauty treatment and medical beauty skin care |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN113456519A (en) | Novel separated skin care product | |
| CN104853779A (en) | Catechin bioavailability enhancer comprising cyclodextrin | |
| CN111671716A (en) | Antioxidant skin color brightening composition and application thereof in cosmetics | |
| EP2883538A1 (en) | Composition for agent for external use | |
| CN111166694A (en) | Soothing, repairing and moisturizing mask liquid and preparation method thereof | |
| CN112587426A (en) | Whitening and freckle removing essence and preparation method thereof | |
| CN114099586A (en) | Application of muskmelon and eggplant fermented juice | |
| JP6957289B2 (en) | Whitening cosmetic composition | |
| JP5865623B2 (en) | External preparation for skin and method for producing the same | |
| JP2013032302A (en) | External preparation for skin and method for producing the same | |
| JP2011201789A (en) | Skin preparation for external use | |
| JP5558332B2 (en) | Scalp hair cosmetics | |
| TWI687237B (en) | Use of extract of victoria cruziana for inducing expression of keratin gene and hyaluronan synthase 2 gene, and enhancing moisture-retaining capacity of skin | |
| CN101485618B (en) | Composition and application thereof as scurf-eliminating and itch-stopping agent | |
| JP2019014672A (en) | Aqueous gel-like composition for skin whitening | |
| CN102793657A (en) | Skin care product containing biological buffering agent | |
| TWI694829B (en) | Use of extract of selaginella tamariscina for inducing expression of keratin gene, hyaluronan synthase gene and filaggrin gene, enhancing mitochondrial activity of cells, enhancing moisture-retaining capacity of skin, and anti-aging | |
| JP2013216637A (en) | Skin external preparation | |
| JP2014001292A (en) | Anthocyanin-containing aqueous composition | |
| JP5865624B2 (en) | External preparation for skin and method for producing the same | |
| CN110623853A (en) | Cleaning and nursing composition and preparation method thereof | |
| CN115068361B (en) | Blue copper peptide double-agent and use method and application thereof | |
| CN109646352A (en) | A kind of hair-washing composition with anti-dandruff performance containing pomegranate rind extract | |
| JP5710189B2 (en) | Skin lotion | |
| WO2018134713A1 (en) | Hair growth retardant composition |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20211001 |
|
| RJ01 | Rejection of invention patent application after publication |